Myelin and axon pathology in a long-term study of PMP22-overexpressing mice

Journal of Neuropathology and Experimental Neurology

Volumn 70, Issue 5, 2011, Pages 386-398

  Verhamme, Camiel ^a   King, Rosalind H M ^b   Ten Asbroek, Anneloor L M A ^a   Muddle, John R ^b   Nourallah, Michelle ^b   Wolterman, Ruud ^a   Baas, Frank ^a   Van Schaik, Ivo N ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Axonal dysfunction; Axonal loss; Charcot Marie Tooth disease type 1A; Demyelination; Dysmyelination; Hereditary motor and sensory neuropathy type Ia

Indexed keywords

MYELIN; PERIPHERAL MYELIN PROTEIN 22;

ADULTHOOD; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEMYELINATION; DISEASE COURSE; DISEASE SEVERITY; FEMALE; GENE OVEREXPRESSION; HEREDITARY MOTOR SENSORY NEUROPATHY; MALE; MOUSE; MYELINATED NERVE; MYELINATION; NERVE CONDUCTION; NERVE FIBER; NERVE FIBER DEGENERATION; NERVOUS SYSTEM ELECTROPHYSIOLOGY; NEUROMUSCULAR DISEASE; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; SCIATIC NERVE; WILD TYPE;

ACTION POTENTIALS; ANIMALS; AXONS; DEMYELINATING DISEASES; ELECTROPHYSIOLOGY; GENOTYPE; MICE; MICE, TRANSGENIC; MYELIN PROTEINS; MYELIN SHEATH; NERVE FIBERS, MYELINATED; NEUROMUSCULAR DISEASES;

EID: 79955524913     PISSN: 00223069     EISSN: 15546578     Source Type: Journal    
DOI: 10.1097/NEN.0b013e318217eba0     Document Type: Article

References (63)

1. Boerkoel CF, Takashima H, Garcia CA, et al. Charcot-Marie-Tooth disease and related neuropathies: Mutation distribution and genotypephenotype correlation. Ann Neurol 2002;51:190-201 (Pubitemid 34111441)
2. Lupski JR, Oca-Luna RM, Slaugenhaupt S, et al. DNA duplication associated with Charcot-Marie-Tooth disease type 1A. Cell 1991;66: 219-32 (Pubitemid 121001361)
3. Raeymaekers P, Timmerman V, Nelis E, et al. Duplication in chromosome 17p11.2 in Charcot-Marie-Tooth neuropathy type 1a (CMT1a). The HMSN Collaborative Research Group. Neuromuscul Disord 1991;1: 93-97
4. Valentijn LJ, Baas F, Wolterman RA, et al. Identical point mutations of PMP-22 in Trembler-J mouse and Charcot-Marie-Tooth disease type 1A. Nat Genet 1992;2:288-91
5. Bird TD. Charcot-Marie-Tooth neuropathy type 1. In: Pagon RA, Bird TD, Dolan CR, Stephens K, eds. Gene Reviews [Internet]. Seattle, WA: University of Washington, 1993: [updated 2010 Sep 14]
6. Amici SA, Dunn WA Jr, Murphy AJ, et al. Peripheral myelin protein 22 is in complex with >6A4 integrin, and its absence alters the Schwann cell basal lamina. J Neurosci 2006;26:1179-89 (Pubitemid 43237051)
7. Hanemann CO, DUrso D, Gabreëls-Festen AA, et al. Mutationdependent alteration in cellular distribution of peripheral myelin protein 22 in nerve biopsies from Charcot-Marie-Tooth type 1A. Brain 2000;123: 1001-6 (Pubitemid 30224195)
8. Fortun J, Go JC, Li J, et al. Alterations in degradative pathways and protein aggregation in a neuropathy model based on PMP22 overexpression. Neurobiol Dis 2006;22:153-64
9. Fortun J, Verrier JD, Go JC, et al. The formation of peripheral myelin protein 22 aggregates is hindered by the enhancement of autophagy and expression of cytoplasmic chaperones. Neurobiol Dis 2007;25:252-65 (Pubitemid 46124007)
10. Verrier JD, Lau P, Hudson L, et al. Peripheral myelin protein 22 is regulated post-transcriptionally by miRNA-29a. Glia 2009;57:1265-79
11. Zhang F, Seeman P, Liu P, et al. Mechanisms for nonrecurrent genomic rearrangements associated with CMT1A or HNPP: Rare CNVs as a cause for missing heritability. Am J Hum Genet 2010;86:892-903
12. Huang J, Wu X, Montenegro G, et al. Copy number variations are a rare cause of non-CMT1A Charcot-Marie-Tooth disease. J Neurol 2010;257: 735-41
13. Weterman MA, van RF, de Wissel M, et al. Copy number variation upstream of PMP22 in Charcot-Marie-Tooth disease. Eur J Hum Genet 2010;18:421-28
14. Berciano J, Garcia A, Calleja J, et al. Clinico-electrophysiological correlation of extensor digitorum brevis muscle atrophy in children with Charcot- Marie-Tooth disease 1A duplication. Neuromuscul Disord 2000;10:419-24 (Pubitemid 30433812)
15. Krajewski KM, Lewis RA, Fuerst DR, et al. Neurological dysfunction and axonal degeneration in Charcot-Marie-Tooth disease type 1A. Brain 2000;123:1516-27 (Pubitemid 30420950)
16. Verhamme C, van Schaik IN, Koelman JHTM, et al. Clinical disease severity and axonal dysfunction in hereditary motor and sensory neuropathy Ia. J Neurol 2004;251:1491-97 (Pubitemid 40169473)
17. Shy ME, Chen L, Swan ER, et al. Neuropathy progression in Charcot- Marie-Tooth disease type 1A. Neurology 2008;70:378-83 (Pubitemid 351653401)
18. Padua L, Pareyson D, Aprile I, et al. Natural history of CMT1A including QoL: A 2-year prospective study. Neuromuscul Disord 2008;18:199-203
19. Verhamme C, van Schaik IN, Koelman JHTM, et al. The natural history of Charcot-Marie-Tooth type 1A in adults: A 5-year follow-up study. Brain 2009;132:3252-62
20. van Dijk JP, Verhamme C, van Schaik IN, et al. Age-related changes in motor unit number estimates in adult patients with Charcot-Marie-Tooth type 1A. Eur J Neurol 2010;17:1098-104
21. Huxley C, Passage E, Manson A, et al. Construction of a mouse model of Charcot-Marie-Tooth disease type 1A by pronuclear injection of human YAC DNA. Hum Mol Genet 1996;5:563-69 (Pubitemid 26141268)
22. Magyar JP, Martini R, Ruelicke T, et al. Impaired differentiation of Schwann cells in transgenic mice with increased PMP22 gene dosage. J Neurosci 1996;16:5351-60 (Pubitemid 26277864)
23. Perea J, Robertson A, Tolmachova T, et al. Induced myelination and demyelination in a conditional mouse model of Charcot-Marie-Tooth disease type 1A. Hum Mol Genet 2001;10:1007-18 (Pubitemid 32447778)
24. Robertson AM, Perea J, McGuigan A, et al. Comparison of a new pmp22 transgenic mouse line with other mouse models and human patients with CMT1A. J Anat 2002;200:377-90 (Pubitemid 34498532)
25. de Waegh S, Brady ST. Altered slow axonal transport and regeneration in a myelin-deficient mutant mouse: The Trembler as an in vivo model for Schwann cellYaxon interactions. J Neurosci 1990;10:1855-65
26. de Waegh SM, Lee VMY, Brady ST. Local modulation of neurofilament phosphorylation, axonal caliber, and slow axonal transport by myelinating Schwann cells. Cell 1992;68:451-63
27. Sancho S, Magyar JP, Aguzzi A, et al. Distal axonopathy in peripheral nerves of PMP22-mutant mice. Brain 1999;122:1563-77 (Pubitemid 29374131)
28. Sahenk Z, Chen L, Mendell JR. Effects of PMP22 duplication and deletions on the axonal cytoskeleton. Ann Neurol 1999;45:16-24 (Pubitemid 29036427)
29. Rogers DC, Fisher EM, Brown SD, et al. Behavioral and functional analysis of mouse phenotype: SHIRPA, a proposed protocol for comprehensive phenotype assessment. Mamm Genome 1997;8:711-13 (Pubitemid 127739700)
30. Robertson AM, King RH, Muddle JR, et al. Abnormal Schwann cell/axon interactions in the Trembler-J mouse. J Anat 1997;190:423-32 (Pubitemid 27182682)
31. King RHM. Myelin Abnormalities. In: Atlas of Peripheral Nerve Pathology. London, UK: Arnold, 1999:95-116
32. Ballin RH, Thomas PK. Changes at the nodes of ranvier during wallerian degeneration: An electron microscope study. Acta Neuropathol 1969;14: 237-49
33. Edgar JM, McLaughlin M, Yool D, et al. Oligodendroglial modulation of fast axonal transport in a mouse model of hereditary spastic paraplegia. J Cell Biol 2004;166:121-31 (Pubitemid 38931922)
34. Spencer PS, Thomas PK. Ultrastructural studies of the dying-back process. II. The sequestration and removal by Schwann cells and oligodendrocytes of organelles from normal and diseases axons. J Neurocytol 1974;3:763-83
35. Vavlitou N, Sargiannidou I, Markoullis K, et al. Axonal pathology precedes demyelination in a mouse model of X-linked demyelinating/type I Charcot-Marie Tooth neuropathy. J Neuropathol Exp Neurol 2010;69: 945-58
36. Gasser HS. The postspike positivity of unmedullated fibers of dorsal root origin. J Gen Physiol 1958;41:613-32
37. Carvalho AA, Vital A, Ferrer X, et al. Charcot-Marie-Tooth disease type 1A: Clinicopathological correlations in 24 patients. J Peripher Nerv Syst 2005;10:85-92 (Pubitemid 40289585)
38. Robaglia-Schlupp A, Pizant J, Norreel JC, et al. PMP22 overexpression causes dysmyelination in mice. Brain 2002;125:2213-21
39. Yiu EM, Burns J, Ryan MM, et al. Neurophysiologic abnormalities in children with Charcot-Marie-Tooth disease type 1A. J Peripher Nerv Syst 2008;13:236-41
40. Roy EP, Gutmann L, Riggs JE. Longitudinal conduction studies in hereditary motor and sensory neuropathy type 1. Muscle Nerve 1989;12: 52-55
41. Killian JM, Tiwari PS, Jacobson S, et al. Longitudinal studies of the duplication form of Charcot-Marie-Tooth polyneuropathy. Muscle Nerve 1996;19:74-78 (Pubitemid 26010954)
42. Gasser HS. Unmedullated fibers originating in dorsal root ganglia. J Gen Physiol 1950;33:651-90
43. Gabreëls-Festen AA, Joosten EM, Gabreëls FJ, et al. Early morphological features in dominantly inherited demyelinating motor and sensory neuropathy (HMSN type I). J Neurol Sci 1992;107:145-54
44. Gabreëls-Festen AA, Bolhuis PA, Hoogendijk JE, et al. Charcot- Marie-Tooth disease type 1A: Morphological phenotype of the 17p duplication versus PMP22 point mutations. Acta Neuropathol (Berl) 1995;90:645-49
45. Hattori N, Yamamoto M, Yoshihara T, et al. Demyelinating and axonal features of Charcot-Marie-Tooth disease with mutations of myelin-related proteins (PMP22, MPZ and Cx32): A clinicopathological study of 205 Japanese patients. Brain 2003;126:134-51 (Pubitemid 36068564)
46. Koike H, Iijima M, Mori K, et al. Nonmyelinating Schwann cell involvement with well-preserved unmyelinated axons in Charcot- Marie-Tooth disease type 1A. J Neuropathol Exp Neurol 2007;66: 1027-36 (Pubitemid 350060370)
47. Saporta MA, Katona I, Lewis RA, et al. Shortened internodal length of dermal myelinated nerve fibres in Charcot-Marie-Tooth disease type 1A. Brain 2009;132:3263-73
48. Martini R, Zielasek J, Toyka KV, et al. Protein zero (P0)-deficient mice show myelin degeneration in peripheral nerves characteristic of inherited human neuropathies. Nat Genet 1995;11:281-86
49. Huxley C, Passage E, Robertson AM, et al. Correlation between varying levels of PMP22 expression and the degree of demyelination and reduction in nerve conduction velocity in transgenic mice. Hum Mol Genet 1998;7:449-58 (Pubitemid 28120635)
50. Jacobs JM, Love S. Qualitative and quantitative morphology of human sural nerve at different ages. Brain 1985;108:897-924 (Pubitemid 16185408)
51. Mirsky R, Jessen KR, Brennan A, et al. Schwann cells as regulators of nerve development. J Physiol Paris 2002;96:17-24 (Pubitemid 34087029)
52. Woodhoo A, Sommer L. Development of the Schwann cell lineage: From the neural crest to the myelinated nerve. Glia 2008;56:1481-90
53. Feltri ML, Suter U, Relvas JB. The function of RhoGTPases in axon ensheathment and myelination. Glia 2008;56:1508-17
54. Kaplan S, Odaci E, Unal B, et al. Chapter 2: Development of the peripheral nerve. Int Rev Neurobiol 2009;87:9-26
55. Wrabetz L, DAntonio M, Pennuto M, et al. Different intracellular pathomechanisms produce diverse Myelin Protein Zero neuropathies in transgenic mice. J Neurosci 2006;26:2358-68 (Pubitemid 44699045)
56. Shy ME, Jani A, Krajewski K, et al. Phenotypic clustering in MPZ mutations. Brain 2004;127:371-84 (Pubitemid 38160322)
57. Suter U, Scherer SS. Disease mechanisms in inherited neuropathies. Nat Rev Neurosci 2003;4:714-26 (Pubitemid 37280151)
58. Dubourg O, Tardieu S, Birouk N, et al. Clinical, electrophysiological and molecular genetic characteristics of 93 patients with X-linked Charcot- Marie-Tooth disease. Brain 2001;124:1958-67 (Pubitemid 32945897)
59. Scherer SS, Xu YT, Nelles E, et al. Connexin32-null mice develop demyelinating peripheral neuropathy. Glia 1998;24:8-20 (Pubitemid 28370208)
60. Pareek S, Notterpek L, Snipes GJ, et al. Neurons promote the translocation of peripheral myelin protein 22 into myelin. J Neurosci 1997;17: 7754-62 (Pubitemid 27426214)
61. Katona I, Wu X, Feely SME, et al. PMP22 expression in dermal nerve myelin from patients with CMT1A. Brain 2009;132:1734-40
62. Birouk N, Gouider R, Le Guern E, et al. Charcot-Marie-Tooth disease type 1A with 17p11.2 duplication. Clinical and electrophysiological phenotype study and factors influencing disease severity in 119 cases. Brain 1997;120:813-23 (Pubitemid 27222986)
63. Garcia CA, Malamut RE, England JD, et al. Clinical variability in two pairs of identical twins with the Charcot-Marie-Tooth disease type 1A duplication. Neurology 1995;45:2090-93